MOH Stock Forecast 2025-2026
Distance to MOH Price Targets
MOH Price Momentum
10 Quality Stocks Worth Considering Now
Researching Molina (MOH) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on MOH and similar high-potential opportunities.
Latest MOH Stock Price Targets & Analyst Predictions
Based on our analysis of 31 Wall Street analysts, MOH has a neutral consensus with a median price target of $348.50 (ranging from $279.00 to $400.00). The overall analyst rating is Buy (7.3/10). Currently trading at $322.19, the median forecast implies a 8.2% upside. This outlook is supported by 6 Buy, 8 Hold, and 1 Sell ratings.
The most optimistic forecast comes from David Macdonald at Truist Securities, projecting a 24.2% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MOH Analyst Ratings
MOH Price Target Range
Latest MOH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MOH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Apr 15, 2025 | Baird | Michael Ha | Neutral | Downgrade | $375.00 |
| Apr 11, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $400.00 |
| Apr 9, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $400.00 |
| Apr 9, 2025 | Guggenheim | Jason Cassorla | Neutral | Initiates | $0.00 |
| Mar 5, 2025 | Wells Fargo | Stephen Baxter | Overweight | Upgrade | $372.00 |
| Mar 3, 2025 | Mizuho | Ann Hynes | Outperform | Maintains | $376.00 |
| Feb 19, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $340.00 |
| Feb 7, 2025 | UBS | Kevin Caliendo | Neutral | Maintains | $325.00 |
| Feb 7, 2025 | Barclays | Andrew Mok | Equal-Weight | Maintains | $339.00 |
| Feb 6, 2025 | Stephens & Co. | Raj Kumar | Equal-Weight | Reiterates | $345.00 |
| Jan 6, 2025 | Truist Securities | David Macdonald | Buy | Maintains | $370.00 |
| Dec 17, 2024 | JP Morgan | John Stansel | Neutral | Assumes | $350.00 |
| Nov 4, 2024 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $362.00 |
| Oct 25, 2024 | Barclays | Andrew Mok | Equal-Weight | Maintains | $372.00 |
| Oct 24, 2024 | Baird | Michael Ha | Outperform | Maintains | $331.00 |
| Oct 24, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $406.00 |
| Oct 1, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $406.00 |
| Sep 10, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $406.00 |
| Aug 19, 2024 | Cantor Fitzgerald | Sarah James | Overweight | Reiterates | $406.00 |
| Aug 5, 2024 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $360.00 |
Molina Healthcare Inc. (MOH) Competitors
The following stocks are similar to Molina based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Molina Healthcare Inc. (MOH) Financial Data
Molina Healthcare Inc. has a market capitalization of $17.62B with a P/E ratio of 15.8x. The company generates $39.16B in trailing twelve-month revenue with a 3.0% profit margin.
Revenue growth is +19.1% quarter-over-quarter, while maintaining an operating margin of +3.7% and return on equity of +27.1%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Molina Healthcare Inc. (MOH) Business Model
About Molina Healthcare Inc.
Provides managed care health plans for low-income individuals.
Molina Healthcare generates revenue by offering health plans through government programs such as Medicaid and Medicare. The company focuses on managing the healthcare needs of low-income and underserved populations, providing services like Medicaid management and Medicare Advantage plans, thus ensuring a steady stream of income from government reimbursements.
Founded in 1980, Molina Healthcare has a strong presence in the U.S. healthcare market, particularly in areas with limited medical resources. The company is recognized for its ability to navigate complex healthcare regulations and is committed to promoting public health policy while ensuring sustainable growth.
Company Information
Sector
Healthcare
Industry
Healthcare Plans
Employees
18,000
CEO
Mr. Joseph Michael Zubretsky
Country
United States
IPO Year
2003
Website
www.molinahealthcare.comMolina Healthcare Inc. (MOH) Latest News & Analysis
Molina (MOH) is unlikely to exceed earnings expectations in its upcoming report due to lacking a favorable combination of key factors. Investors should prepare accordingly.
Molina's expected earnings report may underperform, signaling potential declines in stock value and affecting investor confidence and market positioning.
During a significant four-day market decline, only a few S&P 500 stocks recorded gains.
A significant market decline with few gainers signals investor pessimism and potential volatility, impacting portfolio strategies and stock valuations.
Molina Healthcare's stock has gained over 15% YTD, driven by strong revenue and earnings growth. The company targets $52-$55 billion in premium revenue by 2027, showing resilience amid market challenges.
Molina Healthcare's strong YTD performance and growth strategy indicate stability and resilience, making it attractive amid market volatility, enhancing investor confidence and potential returns.
Three healthcare stocks, primarily in the health insurance sector, have shown strong performance amid recent market turmoil.
Strong performance of healthcare stocks during market turmoil signals resilience in the sector, suggesting potential stability and investment opportunities in health insurance.
The S&P 500 index declined approximately 9.1% last week (Mar 31-Apr 4), marking one of its worst performances, despite large-cap stocks showing resilience.
A 9.1% drop in the S&P 500 signals market volatility and potential bearish trends, affecting investor confidence and strategy, while large-cap stocks may indicate sector resilience.
Lamb Weston, Verizon, AbbVie, and TJX outperformed during a market selloff, attracting investors to tariff-resistant sectors like food, pharmaceuticals, and subscription services.
Stocks like Lamb Weston, Verizon, AbbVie, and TJX are seen as safe havens during market volatility, indicating investor preference for stable, tariff-resistant sectors amid uncertainty.
Frequently Asked Questions About MOH Stock
What is Molina Healthcare Inc.'s (MOH) stock forecast for 2025?
Based on our analysis of 31 Wall Street analysts, Molina Healthcare Inc. (MOH) has a median price target of $348.50. The highest price target is $400.00 and the lowest is $279.00.
Is MOH stock a good investment in 2025?
According to current analyst ratings, MOH has 6 Buy ratings, 8 Hold ratings, and 1 Sell ratings. The stock is currently trading at $322.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MOH stock?
Wall Street analysts predict MOH stock could reach $348.50 in the next 12 months. This represents a 8.2% increase from the current price of $322.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Molina Healthcare Inc.'s business model?
Molina Healthcare generates revenue by offering health plans through government programs such as Medicaid and Medicare. The company focuses on managing the healthcare needs of low-income and underserved populations, providing services like Medicaid management and Medicare Advantage plans, thus ensuring a steady stream of income from government reimbursements.
What is the highest forecasted price for MOH Molina Healthcare Inc.?
The highest price target for MOH is $400.00 from David Macdonald at Truist Securities, which represents a 24.2% increase from the current price of $322.19.
What is the lowest forecasted price for MOH Molina Healthcare Inc.?
The lowest price target for MOH is $279.00 from at , which represents a -13.4% decrease from the current price of $322.19.
What is the overall MOH consensus from analysts for Molina Healthcare Inc.?
The overall analyst consensus for MOH is neutral. Out of 31 Wall Street analysts, 6 rate it as Buy, 8 as Hold, and 1 as Sell, with a median price target of $348.50.
How accurate are MOH stock price projections?
Stock price projections, including those for Molina Healthcare Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.